Literature DB >> 1854608

The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.

P Carnochan1, J C Briggs, G Westbury, A J Davies.   

Abstract

The vascularity of 107 primary cutaneous melanomas has been characterized by morphometric histological analysis. The lesions selected for study were of thickness 0.85-1.25 mm and the aim was to evaluate the prognostic significance of tumour vascularity. Two groups of patients were identified; 86 with no evidence of recurrence after a minimum follow-up period of 5 years and 21 with locoregional recurrence and/or metastasis. The lectin Ulex europaeus type I was used for endothelial cell staining of tissue sections and morphometric analysis was performed to derive the vascular length, surface and volume density from independent measurements of tumour, adjacent dermis and the junctional zone between tumour and underlying tissue. A wide range of values was obtained for each parameter with increased vascularity always found at the tumour base compared with the tumour as a whole. In relation to the adjacent normal dermis, vascularity was generally found to be higher at the tumour base but either higher or lower in the tumour overall. Tumour recurrence could not be predicted by any of the derived vascular parameters either independently or together with other histological and clinical features. This study suggests that tumour vascularity is of no prognostic significance in melanoma of the above thickness range. The highly variable extent of tumour vascularity was not correlated with other clinical or histological parameters, but may have implications for the delivery of pharmaceutical agents used for diagnosis or therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1854608      PMCID: PMC1977287          DOI: 10.1038/bjc.1991.250

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Principles and methods for the morphometric study of the lung and other organs.

Authors:  E R WEIBEL
Journal:  Lab Invest       Date:  1963-02       Impact factor: 5.662

2.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

Review 3.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Lymphatics in primary cutaneous melanoma.

Authors:  M E Fallowfield; M G Cook
Journal:  Am J Surg Pathol       Date:  1990-04       Impact factor: 6.394

Review 5.  Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states.

Authors:  I M Braverman
Journal:  J Invest Dermatol       Date:  1989-08       Impact factor: 8.551

6.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.

Authors:  A Srivastava; P Laidler; R P Davies; K Horgan; L E Hughes
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

7.  Ulex europaeus I lectin as a marker for vascular endothelium in human tissues.

Authors:  H Holthöfer; I Virtanen; A L Kariniemi; M Hormia; E Linder; A Miettinen
Journal:  Lab Invest       Date:  1982-07       Impact factor: 5.662

8.  Cutaneous melanomas. The use of a computer to aid in the investigation of the disease.

Authors:  J C Briggs
Journal:  Pathology       Date:  1985-04       Impact factor: 5.306

9.  Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study.

Authors:  A Srivastava; P Laidler; L E Hughes; J Woodcock; E J Shedden
Journal:  Eur J Cancer Clin Oncol       Date:  1986-10

10.  Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour.

Authors:  A Srivastava; L E Hughes; J P Woodcock; P Laidler
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

  10 in total
  18 in total

1.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

Authors:  O Straume; L A Akslen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.

Authors:  R L Barnhill; M A Levy
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 3.  Intratumor microvessel density as a prognostic factor in cancer.

Authors:  N Weidner
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

4.  Perfusion systems that minimize vascular volume fraction in engineered tissues.

Authors:  James G Truslow; Joe Tien
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

5.  Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination.

Authors:  R M de Waal; M C van Altena; H Erhard; U H Weidle; P T Nooijen; D J Ruiter
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 6.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 7.  Inhibition of angiogenesis for the treatment of metastatic melanoma.

Authors:  Aaron S Mansfield; Svetomir N Markovic
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

Review 8.  Vasculogenic mimicry and tumor angiogenesis.

Authors:  R Folberg; M J Hendrix; A J Maniotis
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

9.  Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.

Authors:  K J Busam; M Berwick; K Blessing; K Fandrey; S Kang; T Karaoli; J Fine; A J Cochran; W L White; J Rivers
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

10.  Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

Authors:  Soheil S Dadras; Thomas Paul; Jennifer Bertoncini; Lawrence F Brown; Alona Muzikansky; David G Jackson; Ulf Ellwanger; Claus Garbe; Martin C Mihm; Michael Detmar
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.